Finally, although we have strong evidence from the literature that FGF23 is a mediator in the association of iron deficiency and EPO with mortality, we cannot exclude that an unmeasured cause of mortality or alternative potential mediators have influenced the current results. Here, EPO is linked to Iron deficiency anemia.